Janux Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−1.55%
vs ±10.7% implied · ×0.14
shaded = implied · ▲▼ = realized
No thesis.
Janux Therapeutics, Inc.
17.48
−0.35 · −1.96%
post 17.23 −1.43%
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $171.9M | 18.27% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $94.2M | 10.02% | +12.91% | |
| 3 | Prosight ManagementProsight | $58.4M | 6.21% | +7.17% | |
| 4 | State StreetState Streetindex-like | $46.2M | 4.91% | +21.95% | |
| 5 | FMRFMR | $37.1M | 3.94% | −4.85% | |
| 6 | Federated InvestorsFederated Investors | $36.1M | 3.84% | +4241.19% | |
| 7 | Point72 Asset ManagementPoint72 | $30.6M | 3.26% | +72.46% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $28.5M | 3.03% | +2.54% | |
| 9 | TCG Crossover ManagementTCG Crossover | $27.5M | 2.92% | 0.00% | |
| 10 | Alyeska Investment GroupAlyeska Investment | $25.3M | 2.69% | +2.88% | |
| 11 | Wellington Management GroupWellington | $23.2M | 2.46% | −5.65% | |
| 12 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $20.4M | 2.17% | +3.14% | |
| 13 | Citadel AdvisorsCitadel | $19.4M | 2.07% | +184.50% | |
| 14 | Two Sigma InvestmentsTwo Sigma | $18.5M | 1.97% | +939.85% | |
| 15 | Geode Capital ManagementGeodeindex-like | $18.5M | 1.97% | +5.01% | |
| 16 | Algert GlobalAlgert Global | $17.1M | 1.81% | +150.54% | |
| 17 | D. E. ShawD. E. Shaw | $16.8M | 1.79% | +1014.40% | |
| 18 | Goldman Sachs GroupGoldman Sachs | $14.6M | 1.56% | +58.25% | |
| 19 | Bank of AmericaBank of America | $14.0M | 1.49% | +13.57% | |
| 20 | Morgan StanleyMorgan Stanley | $12.9M | 1.37% | +18.90% | |
| 21 | Nantahala Capital ManagementNantahala | $12.4M | 1.32% | 0.00% | |
| 22 | Qube Research & TechnologiesQube Research & Technologies | $10.8M | 1.15% | +256.11% | |
| 23 | Squarepoint OpsSquarepoint Ops | $8.2M | 0.87% | −11.87% | |
| 24 | Orbimed AdvisorsOrbimed | $8.1M | 0.86% | −46.66% | |
| 25 | Millennium ManagementMillennium | $7.7M | 0.82% | +30.44% |
196 managers report $940.7M of Janux Therapeutics on form 13F for the quarter ended Jun 30 '26. 22 of them hold 80% of it; RA Capital Management is largest at 18.27%.
Linked news
Expected move
Inputs8Q avg ±2.7%·×5.39·rich
straddle ±19.8%
spot 17.47exp Nov 20ATM strike 17.5ATM straddle 4.07IV 122%